GetTopicDetailResponse(id=d5df9221e05, topicName=貝葉斯, introduction=貝葉斯, content=null, image=null, comments=1, allHits=1917, url=https://h5.medsci.cn/topic?id=92217, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=11817, tagList=[TagDto(tagId=11817, tagName=貝葉斯)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1248026, encodeId=a8e01248026c9, content=通用型<a href='/topic/show?id=d536e14259d' target=_blank style='color:#2F92EE;'>#癌癥疫苗#</a>在晚期<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a>中的免疫原性和療效，不過效果也只能說可以，并談不上令人驚艷！不過研究設(shè)計(jì)，<a href='/topic/show?id=d5df9221e05' target=_blank style='color:#2F92EE;'>#貝葉斯#</a>的Ib期和IIa期降級(jí)<a href='/topic/show?id=925fe34453b' target=_blank style='color:#2F92EE;'>#研究設(shè)計(jì)#</a>，值得學(xué)習(xí)，現(xiàn)在用的越來越多了, objectTitle=J Clin Oncol：通用型癌癥疫苗在晚期非小細(xì)胞肺癌中的免疫原性和療效, objectType=article, longId=738665, objectId=219ae3866547, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220908/1662614880255_2110107.JPG, objectUrl=/article/show_article.do?id=219ae3866547, replyNumber=0, likeNumber=210, createdTime=2022-09-09, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=219ae3866547, moduleTitle=J Clin Oncol：通用型癌癥疫苗在晚期非小細(xì)胞肺癌中的免疫原性和療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=219ae3866547)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
